Wellington Management Group’s Cytek Biosciences CTKB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,517,214
| Closed | -$9.85M | – | 1944 |
|
|
2024
Q4 | $9.85M | Sell |
1,517,214
-489,925
| -24% | -$3.18M | ﹤0.01% | 1196 |
|
|
2024
Q3 | $11.1M | Sell |
2,007,139
-128,568
| -6% | -$712K | ﹤0.01% | 1141 |
|
|
2024
Q2 | $11.9M | Buy |
2,135,707
+780,737
| +58% | +$4.36M | ﹤0.01% | 1116 |
|
|
2024
Q1 | $9.09M | Buy |
1,354,970
+63,712
| +5% | +$428K | ﹤0.01% | 1166 |
|
|
2023
Q4 | $11.8M | Sell |
1,291,258
-154,280
| -11% | -$1.41M | ﹤0.01% | 1066 |
|
|
2023
Q3 | $7.98M | Buy |
1,445,538
+99,170
| +7% | +$547K | ﹤0.01% | 1160 |
|
|
2023
Q2 | $11.5M | Buy |
1,346,368
+111,162
| +9% | +$949K | ﹤0.01% | 1072 |
|
|
2023
Q1 | $11.4M | Buy |
+1,235,206
| New | +$11.4M | ﹤0.01% | 1068 |
|
|
2022
Q4 | – | Sell |
-31,981
| Closed | -$471K | – | 2015 |
|
|
2022
Q3 | $471K | Buy |
+31,981
| New | +$471K | ﹤0.01% | 1814 |
|
|
2022
Q2 | – | Sell |
-41,617
| Closed | -$449K | – | 2094 |
|
|
2022
Q1 | $449K | Buy |
+41,617
| New | +$449K | ﹤0.01% | 1943 |
|